-1.86419350328395E-05 0 0 8.38887076477775E-05 0.00255394509950134 0.00663652887169678 0.00396141119448199 0.00135154028988192
Sign Up Today X
Thanks for submitting the form.
Stockreport

J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot [Yahoo! Finance]

Intuitive Surgical, Inc. (ISRG)  More Company Research Source: Yahoo! Finance
Last intuitive surgical, inc. earnings: 4/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=122359&p=irol-irhome
system, winning an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) for the technology. The IDE will allow the medtech giant to conduct clinical trials at US sites with the robotic surgical system called Ottava. Such trials are needed to collect safety and effectiveness data to support market clearance applications. J&J MedTech has not revealed further details about the clinical programme, saying only it “will now prepare clinical trial sites to receive Ottava systems, enrol patients, and begin surgical cases.” The company first shared details on the Ottava robot nearly three years ago. Delays have meant that the surgery system was pushed back by two years – J&J cited the Covid-19 pandemic and technical challenges as factors. The IDE grant marks the first time J&J has lifted the veils on the updated features of the robotic system. Ottava features four, low-profile robotic arms incorporated into the operating table that can be packed away un [Read more]
IMPACT SNAPSHOT EVENT TIME: ISRG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ISRG alerts
from News Quantified
ISRG
NEWS
ISRG
Earnings
ISRG
Analyst Actions
ISRG
SEC Filings
Stockreport

J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot [Yahoo! Finance]

Intuitive Surgical, Inc.  (ISRG) 
More Company Research Source: Yahoo! Finance
Last intuitive surgical, inc. earnings: 4/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=122359&p=irol-irhome
system, winning an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) for the technology. The IDE will allow the medtech giant to conduct clinical trials at US sites with the robotic surgical system called Ottava. Such trials are needed to collect safety and effectiveness data to support market clearance applications. J&J MedTech has not revealed further details about the clinical programme, saying only it “will now prepare clinical trial sites to receive Ottava systems, enrol patients, and begin surgical cases.” The company first shared details on the Ottava robot nearly three years ago. Delays have meant that the surgery system was pushed back by two years – J&J cited the Covid-19 pandemic and technical challenges as factors. The IDE grant marks the first time J&J has lifted the veils on the updated features of the robotic system. Ottava features four, low-profile robotic arms incorporated into the operating table that can be packed away un [Read more]
IMPACT SNAPSHOT
EVENT TIME:
ISRG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS